Gastrointestinal Cancer News

Researchers from the Veterans Affairs Puget Sound Health Care System, Seattle, Washington, found that the hepatocellular carcinoma MELD exception policy reduces liver transplantation-related survival benefit in patients with hepatocellular carcinoma, according to published findings.

Neoadjuvant chemoradiotherapy followed by surgical resection should be regarded as the standard of care for patients with locally advanced resectable esophageal or esophagogastric junction cancer, according to the results of a randomized, controlled trial.

Researchers found that the use of positron emission tomography with [18F]FDG in combination with magnetic resonance imaging was more accurate in detecting liver metastases compared with positron emission tomography with computed tomography, according to published findings.

Researchers at Hiroshima University found circulating tumor DNA to be an accurate predictor of hepatocellular carcinoma recurrence within 2 years of liver resection, according to newly published data.

The AGA announced a new guideline on the diagnosis and management of Lynch syndrome, which recommends that all patients with colorectal cancer should be tested for the hereditary condition.

In a prospective study, researchers in Italy found that compensated patients with hepatocellular carcinoma who permanently discontinued therapy with Nexavar had a longer post-treatment survival, according to published findings in Hepatology.

Smokeless tobacco accounts for more than 6 million disability-adjusted life-years lost and more than a quarter-million deaths each year worldwide, according to an analysis of data from more than 100 countries.

The National Cancer Institute awarded Wei Jia, MD, shared resources director at the University of Hawaii Cancer Center, a $2.7 million grant for his liver cancer prevention study, according to a press release from the University of Hawaii Cancer Center.

The U.S. Preventive Services Task Force recommends men and women at average risk for colorectal cancer undergo screening between the ages of 50 and 75 years.

The number of lymph nodes removed during lymphadenectomy may not influence 5-year all-cause or disease-specific survival among patients with esophageal cancer, according to the results of a cohort study.